[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.139.136. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 164
Citations 0
From JAMA's Daily News Site
May 15, 2013

Selections From News@JAMA and JAMA Forum

JAMA. 2013;309(19):1983. doi:10.1001/jama.2013.5120

A daily dose of allergens under the tongue appears to be effective in desensitizing patients with allergic rhinitis or asthma to respiratory allergens.

In a recent review article, researchers found moderate evidence supporting the efficacy of sublingual therapy. In 8 of 13 studies they evaluated, patients with asthma who were treated with this approach had a 40% or greater improvement in symptoms compared with a control or alternate therapy group. Evidence of efficacy for allergic rhinitis was moderate: 9 of 36 studies showed a 40% or more improvement in symptoms. Although common in Europe, sublingual therapy isn't approved by the US Food and Drug Administration.

First Page Preview View Large
First page PDF preview
First page PDF preview
×